Kolla Bhanu Prakash, Oesterle Tyler, Gold Mark, Southwick Frederick, Rummans Teresa
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States of America.
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, United States of America.
J Neurol Sci. 2020 Apr 15;411:116719. doi: 10.1016/j.jns.2020.116719. Epub 2020 Jan 31.
Prevalence of infectious diseases is substantially higher among patients with substance use disorders (SUD). Factors associated with drug use including sharing needles and injecting supplies, presence of contaminants in drugs and drug use related paraphernalia, risky behaviors associated with drug use, immune suppression secondary to chronic drug use, poverty and homelessness all increase the risk of infections. Persons with SUD have low rates of health care utilization and may miss opportunities for early diagnosis and care of infectious complications of substance use. When infectious diseases are comorbid with drug use, they are associated with substantial morbidity and mortality and result in significant healthcare costs. Patients with SUD may be rescued from an overdose, detoxified or treated for a SUD but facilities and clinicians are often reluctant to assume responsibility for evaluation and treatment of concurrent infectious or medical diseases. Increased screening for these disorders, utilizing vaccinations and other preventative strategies including clean supplies and safe injecting sites and providing comprehensive substance use and infectious disease treatment have the potential to significantly improve patient related outcomes and enhance public health. In this paper we review the prevalence of various common infectious diseases among persons who use drugs, their clinical presentation, mode of transmission, screening and diagnosis. We detail some of the common mechanisms by which persons who use drugs are at increased risk of contracting infections. We also discuss preventive and treatment strategies for infectious diseases occurring in the context of SUD.
物质使用障碍(SUD)患者中传染病的患病率显著更高。与药物使用相关的因素包括共用针头和注射用品、药物及与药物使用相关的用具中存在污染物、与药物使用相关的危险行为、长期药物使用继发的免疫抑制、贫困和无家可归,所有这些都会增加感染风险。患有SUD的人医疗保健利用率较低,可能会错过对物质使用的感染并发症进行早期诊断和治疗的机会。当传染病与药物使用并存时,它们会导致大量发病和死亡,并产生巨大的医疗费用。患有SUD的患者可能会从药物过量中获救、戒毒或接受SUD治疗,但医疗机构和临床医生往往不愿承担对并发感染性疾病或内科疾病进行评估和治疗的责任。增加对这些疾病的筛查、利用疫苗接种和其他预防策略,包括清洁用品和安全注射场所,并提供全面的物质使用和传染病治疗,有可能显著改善患者相关结局并促进公共卫生。在本文中,我们回顾了吸毒者中各种常见传染病的患病率、临床表现、传播方式、筛查和诊断。我们详细介绍了吸毒者感染风险增加的一些常见机制。我们还讨论了SUD背景下传染病的预防和治疗策略。